References
- Achiume, E. T. (2022, June 14). UN expert urges states to end ‘vaccine apartheid’. United Nations. https://www.ohchr.org/en/press-releases/2022/06/un-expert-urges-states-end-vaccine-apartheid
- Africa Center for Disease Control. (2021, April 13). African Union and Africa CDC launches Partnerships for African Vaccine Manufacturing (PAVM) framework to achieve it and signs 2 MoUs. Africa CDC. https://africacdc.org/news-item/african-union-and-africa-cdc-launches-partnerships-for-african-vaccine-manufacturing-pavm-framework-to-achieve-it-and-signs-2-mous/
- Amnesty International. (2021). COVID-19: Time for countries blocking TRIPS waiver to support lifting of restrictions (News release, October 1st). https://www.amnesty.org/en/latest/news/2021/10/covid-19-time-for-countries-blocking-trips-waiver-to-support-lifting-of-restrictions/?nbsp
- Apuzzo, M., & Gebrekidan, S. (2021, February 24). Governments sign secret vaccine deals. Here’s what they hide. The New York Times. https://www.nytimes.com/2021/01/28/world/europe/vaccine-secret-contracts-prices.html
- Banco, E., Furlong, A., & Pfahler, L. (2022, September 14). How Bill Gates and partners used their clout to control the global Covid response — with little oversight. Politico. https://www.politico.com/news/2022/09/14/global-covid-pandemic-response-bill-gates-partners-00053969
- BBC. (2021, September 23). COVAX: How many COVID vaccines have the US and other G7 countries pledged? BBC News. https://www.bbc.com/news/world-55795297
- Bigdeli, M., Laing, R., Tomson, G., & Baber, Z. U. D. (2015). Medicines and universal health coverage: Challenges and opportunities. Journal of Pharmaceutical Policy and Practice, 8(8), 1–3. https://doi.org/10.1186/s40545-015-0028-4
- Byanyima, W. (2021, February 3). A global vaccine apartheid is unfolding. People’s lives must come before profits. UNAIDS. https://www.unaids.org/en/20210203_oped_guardian
- Chenchula, S., Karunakaran, P., Sharma, S., & Chavan, M. (2022). Current evidence on efficacy of COVID-19 booster dose vaccination against the omicron variant: A systematic review. Journal of Medical Virology, 94(7), 2969–2976. https://doi.org/10.1002/jmv.27697
- Cheney, C. (2021, May 7). Gates Foundation reverses course on COVID-19 vaccine patents. Devex.https://www.devex.com/news/gates-foundation-reverses-course-on-covid-19-vaccine-patents-99810
- Commission on Intellectual Property Rights. (2002, February 21–22). Conference: How intellectual property rights could work better for developing countries and poor people. Transcript Session 6: Medicines and Vaccines. http://www.iprcommission.org/papers/pdfs/conferences/session_6.pdf
- Council for Trade-Related Aspects of Intellectual Property Rights. (2020a, October 2). Waiver from certain provisions of the TRIPS Agreement for the prevention, containment and treatment of COVID-19. World Trade Organization. https://docs.wto.org/dol2fe/Pages/SS/directdoc.aspx?filename=q:/IP/C/W669.pdf&Open=True
- Council for Trade-Related Aspects of Intellectual Property Rights. (2020b, November 23). Examples of IP issues and barriers in COVID-19 pandemic: Communication from South Africa. World Trade Organization. https://docs.wto.org/dol2fe/Pages/SS/directdoc.aspx?filename=q:/IP/C/W670.pdf&Open=True
- Council for Trade-Related Aspects of Intellectual Property Rights. (2021, July 30). Minutes of meeting. World Trade Organization. https://docs.wto.org/dol2fe/Pages/SS/directdoc.aspx?filename=q:/IP/C/M98A1.pdf&open=True
- COVID-19 Vaccine Tracker. (2022). By the number. https://covid19.trackvaccines.org
- da Fonseca, E. M., Kenneth, S. C., & de Moraes Achcar, H. (2023). Vaccine technology transfer in a global health crisis: Actors, capabilities, and institutions. Research Policy, 52(4), 104739. https://doi.org/10.1016/j.respol.2023.104739
- De Haan, E., & Ten Kate, A. (2023). Pharma’s pandemic profits: Pharma profits from COVID-19 vaccines. Centre for Research on Multinational Corporations. https://www.somo.nl/wp-content/uploads/2023/02/SOMO-Pharmas-Pandemic-Profits.pdf.
- Duke Global Health Innovation Center. (2023). Launch and scale speedometer. https://launchandscalefaster.org/covid-19/vaccinepurchases
- Dyer, O. (2021). COVID-19: Countries are learning what others paid for vaccines. British Medical Journal, 372, n281. https://doi.org/10.1136/bmj.n281
- Eccleston-Turner, M., & Rourke, M. (2021). Arguments against the inequitable distributions of vaccines using the access and benefit sharing transaction. International and Comparative Law Quarterly, 70(4), 825–858. https://doi.org/10.1017/S0020589321000294
- Eccleston-Turner, M., & Upton, H. (2021). International collaboration to ensure equitable access to vaccines for COVID-19: The ACT-accelerator and the COVAX facility. The Milbank Quarterly: A Multidisciplinary Journal of Population Health and Health Policy, 99(2), 426–449. https://doi.org/10.1111/1468-0009.12503
- Espiner, T. (2021, 12 November). AstraZeneca to take profits from Covid vaccine. BBC News. https://www.bbc.com/news/business-59256223
- Feinmann, J. (2021). COVID-19: Global vaccine production is a mess and shortages are down to more than just hoarding. British Medical Journal, 375, n2375. https://doi.org/10.1136/bmj.n2375
- Fidler, D. P. (2010). Negotiating equitable access to influenza vaccines: Global health diplomacy and the controversies surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1. PLoS Medicine, 7(5), e1000247. https://doi.org/10.1371/journal.pmed.1000247
- Forman, L. (2008). "Rights" and wrongs: What utility for the right to health in reforming trade rules on medicines? Health and Human Rights, 10(2), 37–52. https://doi.org/10.2307/20460102
- Forman, L. (2012). From TRIPS-Plus to rights-plus? Exploring right to health impact assessment of trade-related intellectual property rights through the Thai experience. Asian Journal of WTO and International Health Law and Policy, 7(2), 347–375.
- Forman, L., Perehudoff, K., & Wu, C. (forthcoming). International trade governance: Free trade and intellectual property threatens public health. In L. O. Gostin & B. M. Meier (Eds.), Global health law & policy: Ensuring justice for a healthier world (pp. 1–67). Oxford University Press.
- Geddes, L. (2021, July 19). Why Africa needs to manufacture its own vaccines. Gavi, the Vaccine Alliance. https://www.gavi.org/vaccineswork/why-africa-needs-manufacture-its-own-vaccines
- Ghebreyesus, T. A. (2021, May 17). Director-general's opening remarks at Paris Peace Forum spring meeting. World Health Organization. https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-paris-peace-forum-spring-meeting-17-may-2021
- Glassman, A., Kenny, C., & Yang, G. (2022, February 9). COVID-19 vaccine development and rollout in historical perspective. Center for Global Development. https://www.cgdev.org/publication/covid-19-vaccine-development-and-rollout-historical-perspective
- Gleeson, D., Lexchin, J., Labonte, R., Townsend, B., Gagnon, M., Kohler, J., Forman, L., & Shadlen, K. (2019). Analysing the impact of trade and investment agreements on pharmaceutical policy: Provisions, pathways and potential impacts. Globalization and Health, 15(Supplement 1, 78), 1–17.
- Global Alliance for Vaccines and Immunizations. (2022, March 16). Break COVID now: The Gavi COVAX AMC investment opportunity. GAVI website: https://www.gavi.org/gavi-covax-amc-2022-investment-opportunity
- Goldman, A. (2018, March 15). 13 NGOs call on USTR to support Colombia in special 301 following pressure over legal access to meds efforts. Knowledge Ecology International. https://www.keionline.org/27256
- Green, A. (2021, October 7). Where are we on COVID-19 after a year of TRIPS waiver negotiations? Devex. https://www.devex.com/news/sponsored/where-are-we-on-covid-19-after-a-year-of-trips-waiver-negotiations-101795
- Green, A. (2022a, June 17). WTO finally agrees on a TRIPS deal. But not everyone is happy. Devex. https://www.devex.com/news/sponsored/wto-finally-agrees-on-a-trips-deal-but-not-everyone-is-happy-103476
- Green, A. (2022b, September 15). Little progress on COVID drugs agreement at WTO, civil society warns. Devex. https://www.devex.com/news/sponsored/little-progress-on-covid-drugs-agreement-at-wto-civil-society-warns-103990
- Hassan, F., Yamey, G., & Abbasi, K. (2021). Profiteering from vaccine inequity: A crime against humanity? British Medical Journal, 374, n2027. https://doi.org/10.1136/bmj.n2027
- Healthworld. (2021, June 13). Bangladesh signs deal to buy Chinese COVID-19 vaccines, price remains undisclosed. Healthworld from the Economic Times. https://health.economictimes.indiatimes.com/news/industry/bangladesh-signs-deal-to-buy-chinese-covid-19-vaccines-price-remains-undisclosed/83478590
- Hunter, D. J., Abdool Karim, S. S., Baden, L. R., Farrar, J. J., Hamel, M. B., Longo, D. L., Morrissey, S., & Rubin, E. J. (2022). Addressing vaccine inequity — COVID-19 vaccines as a global public good. New England Journal of Medicine, 386(12), 1176–1179. https://doi.org/10.1056/NEJMe2202547
- Ibrahim, I. A. (2021). Overview of export restrictions on COVID-19 vaccines and their components. American Society of International Law Insights, 25(10), 1–6. https://www.asil.org/insights/volume/25/issue/10
- Independent Panel for Pandemic Preparedness & Response. (2021, May). Access to vaccines, therapeutics, and diagnostics. https://theindependentpanel.org/mainreport/background-paper-5-access-to-vaccines-therapeutics-and-diagnostics/
- International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). (2020, October 16). IFPMA Statement on ‘Intellectual Property and COVID-19’. IFPMA. https://www.ifpma.org/resource-centre/ifpma-statement-on-intellectual-property-and-covid-19/
- International Monetary Fund. (2023). World Economic Outlook. https://www.imf.org/en/publications/weo
- Jones, L., Palumbo, D. & Brown, D. (2021, January 24). Coronavirus: How the pandemic has changed the world economy. BBC News. https://www.bbc.com/news/business-51706225
- Kavanagh, M. M., Gostin, L. O., & Sunder, M. (2021). Sharing technology and vaccine doses to address global vaccine inequity and end the COVID-19 pandemic. JAMA, 326(3), 219–220. https://doi.org/10.1001/jama.2021.10823
- Koller, C. N., Schwerzmann, C. J., Lang, A. S. A., Alexiou, E., & Krishnakumar, J. (2021). Addressing different needs: The challenges faced by India as the largest vaccine manufacturer while conducting the world’s biggest COVID-19 vaccination campaign. Epidemiologia, 2(3), 454–470. https://doi.org/10.3390/epidemiologia2030032
- Kremer, M., Levin, J., & Snyder, C. M. (2022). Designing advance market commitments for new vaccines. Management Science, 68(7), 4786–4814. https://doi.org/10.1287/mnsc.2021.4163
- Ledford, H., Cyranosk, D., & Van Noorden, R. (2020, December 2). The UK has approved a COVID vaccine — here's what scientists now want to know. Nature. Accessed from: https://www.nature.com/articles/d41586-020-03441-8
- Light, D. W., & Lexchin, J. (2021). The costs of coronavirus vaccines and their pricing. Journal of the Royal Society of Medicine, 114(11), 502–504. https://doi.org/10.1177/01410768211053006
- Linnane, C. (2021, October 8). U.N. head says vaccine inequity is not just immoral but also ‘stupid,’ as U.S. daily case tally falls below 100,000 for first time since early August. Market Watch. https://www.marketwatch.com/story/un-head-says-vaccine-inequity-not-just-immoral-but-also-stupid-as-u-s-daily-case-tally-falls-below-100-000-for-first-time-since-early-august-11633705265
- Lu, Y., Hernandez, P., Abegunde, D., & Edejer, T. (2011). The world medicines situation 2011: Medicine expenditures. World Health Organization.
- Maxmen, A. (2021). Scientists hail historic malaria vaccine approval — but point to challenges ahead. Nature. https://doi.org/10.1038/d41586-021-02755-5
- Mazumdar, T. (2021, May 17). India’s COVID crisis hits COVAX vaccine-sharing scheme. BBC news. https://www.bbc.com/news/world-57135368
- Medecins Sans Frontieres. (2015, January). A timeline of U.S. attacks on India’s patent law & generic competition. Medecins Sans Frontieres Access Campaign. https://msfaccess.org/sites/default/files/2018-10/IP_Timeline_US%20pressure%20on%20India_Sep%202014_0.pdf
- Medicines Patent Pool. (2021, November). Elisa Antibody Technology. Medicines Patent Pool. https://medicinespatentpool.org/licence-post/elisa-antibody-technology
- Medicines Patent Pool. (2022, April 19). WHO and MPP announce names of 15 manufactures to receive training from mRNA technology transfer hub MPP. Medicines Patient Pool. Retrieved April 26, 2022, from https://medicinespatentpool.org/news-publications-post/who-and-mpp-announce-names-of-15-manufactures-to-receive-training-from-mrna-technology-transfer-hub
- Moon, S., Armstrong, J., Hutler, B., Upshur, R., Katz, R., Atuire, C., Bhan, A., Emanuel, E., Faden, R., Ghimire, P., Greco, D., Ho, C. W. L., Kochhar, S., Schaefer, G. O., Shamsi-Gooshki, E., Singh, J. A., Smith, M. J., & Wolff, W. (2022). Governing the access to COVID-19 tools accelerator: Towards greater participation, transparency, and accountability. The Lancet, 399(10323), 487–494. https://doi.org/10.1016/S0140-6736(21)02344-8
- Nakkazi, E. (2021, February 3). Uganda defends price paid for AstraZeneca COVID-19 vaccine; New study suggests vaccine could cut transmission by two-thirds. Health Policy Watch. https://healthpolicy-watch.news/uganda-defends-astrazeneca-price-says-its-not-higher-than-other-countries/
- New, W. (2019, February 13). Malaysia still under pressure to make hepatitis C medicine more expensive. Intellectual Property Watch. https://www.ip-watch.org/2019/02/13/malaysia-still-pressure-make-hepatitis-c-medicine-expensive/
- Organisation for Economic Co-operation and Development. (2021). Compare your country: Official development assistance. Public Tableau. https://public.tableau.com/app/profile/oEcdondevelopment/viz/ODA_GNI/ODA1960-2020
- Otieno-Sumba, E. (2021). Necropolitics at large: Pandemic politics and the coloniality of the global access gap. Critical Studies on Security, 9(1), 48–52. https://doi.org/10.1080/21624887.2021.1904354
- Otu, A., Osifo-Dawodu, E., Atuhebwe, P., Agogo, E., & Ebenso, B. (2021). Beyond vaccine hesitancy: Time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism. The Lancet Microbe, 2(8), E347–E348. https://doi.org/10.1016/S2666-5247(21)00126-9
- Paquin, S., & Plouffe-Malette, K. (2023). The WTO and the COVID-19 “vaccine apartheid”: Big pharma and the minefield of patents. Politics and Governance, 11(1), 261–271. https://doi.org/10.17645/pag.v11i1.6177
- Paun, C., & Furlong, A. (2021, February 22). Poorer countries hit with higher price tag for Oxford/AstraZeneca vaccine. Politico. https://www.politico.eu/article/astrazeneca-vaccine-cost-higher-in-poorer-countries-coronavirus/
- Pharmaceutical Manufacturer’s Association and Others v. (1998). The President of the Republic of South Africa (PMA) case no. 4183/98, Founding Affidavit.
- Ritchie, H., Mathieu, E., Rodes-Guirao, L., Appel, C., Giattino, C., Ortiz-Ospina, E., Hasell, J., Macdonald, B., Beltekian, D., & Roser, M. (2023). Coronavirus (COVID-19) vaccinations. Our World in data. https://ourworldindata.org/covid-vaccinations
- Rodriguez, L. (2021, July 21). Pfizer-BioNTech will start producing COVID-19 vaccines in South Africa in 2022. Global Citizen. https://www.globalcitizen.org/en/content/pfizer-biontech-covid-vaccine-south-africa/
- Smith, R. D., Correa, C., & Oh, C. (2009). Trade, TRIPS, and pharmaceuticals. The Lancet, 373(9664), 684–691. https://doi.org/10.1016/S0140-6736(08)61779-1
- Sparke, M., & Levy, O. (2023). Immunizing against access? Philanthrocapitalist COVID vaccines and the preservation of patent monopolies. In K. Mitchell & P. Pallister-Wilkins (Eds.), The Routledge international handbook of critical philanthropy and humanitarianism (pp. 71–93). Routledge.
- Sparke, M., & Williams, O. D. (2022). Neoliberal disease: COVID-19, Co-pathogenesis and global health insecurities. Environment and Planning A: Economy and Space, 54(1), 15–32. https://doi.org/10.1177/0308518X211048905
- Stein, F. (2021). Risky business: COVAX and the financialization of global vaccine equity. Globalization and Health, 17(1), 112. https://doi.org/10.1186/s12992-021-00763-8
- Storeng, K. T., de Bengy Puyvallée, A., & Stein, F. (2021). COVAX and the rise of the ‘super public private partnership’ for global health. Global Public Health, 22, 1–17. https://doi.org/10.1080/17441692.2021.1987502
- Sullivan, H. (2021, January 22). South Africa paying more than double EU price for Oxford vaccine. The Guardian. https://www.theguardian.com/world/2021/jan/22/south-africa-paying-more-than-double-eu-price-for-oxford-astrazeneca-vaccine
- Suneja, K. (2023, January 13). Will redouble efforts to extend TRIPS waiver to Covid-19 diagnostics, therapeutics: Goyal. Economic Times. https://economictimes.indiatimes.com/news/economy/foreign-trade/will-redouble-efforts-to-extend-trips-waiver-to-covid-19-diagnostics-therapeutics-goyal/articleshow/96970506.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
- t’Hoen, E. (2022). A plan to fix vaccine inequity offers false comfort. Barron’s. https://www.barrons.com/articles/trips-waiver-quad-compromise-wto-covid-vaccines-equity-51652118609
- t’Hoen, E., Berger, J., Calmy, A., & Moon, S. (2011). Driving a decade of change: HIV/AIDS, patents and access to medicines for all. Journal of the International AIDS Society, 14(1), 15. https://doi.org/10.1186/1758-2652-14-15
- UNAIDS. (2023). https://www.unaids.org/en
- UNICEF. (2023). COVID-19 vaccine market dashboard. Unicef Supply Division. https://www.unicef.org/supply/covid-19-vaccine-market-dashboard
- United Nations. (1974, November 30). International Convention on the Suppression and Punishment of the Crime of Apartheid. United Nations General Assembly. https://www.refworld.org/docid/3ae6b3c00.html
- United Nations. (2015). Ensure healthy lives and promote well-being for all at all ages. United Nations Department of Economic and Social Affairs. https://sdgs.un.org/goals/goal3
- United Nations. (2021a). The sustainable development goals report 2021. https://unstats.un.org/sdgs/report/2021/The-Sustainable-Development-Goals-Report-2021.pdf
- United Nations. (2021b). Strengthen the means of implementation and revitalize the Global Partnership for Sustainable Development. United Nations Statistics Division. https://unstats.un.org/sdgs/report/2021/goal-17/.
- United Nations. (2022). The sustainable development goals report 2022. https://unstats.un.org/sdgs/report/2022/The-Sustainable-Development-Goals-Report-2022.pdf
- United Nations Committee on Economic, Social and Cultural Rights. (2005, November 7–25). General comment no. 17 (2013): The right of everyone to benefit from the protection of the moral and material interests resulting from any scientific, literary or artistic production of why he or she is the author (article 15, paragraph 1(c) of the Covenant). United Nations Digital Library. https://digitallibrary.un.org/record/566430?ln=en
- United Nations Committee on Economic, Social and Cultural Rights. (2020a, April 30). General Comment No. 25 (2020) on science and economic, social and cultural rights (article 15 (1) (b), (2), (3) and (4) of the International Covenant on Economic, Social and Cultural Rights). United Nations Digital Library. https://digitallibrary.un.org/record/3899847?ln=en
- United Nations Committee on Economic, Social and Cultural Rights. (2020b, November 27). Statement on universal and equitable access to vaccines for the coronavirus disease (COVID-19). United Nations Digital Library. https://digitallibrary.un.org/record/3897801?ln=en
- United Nations Committee on Economic, Social and Cultural Rights. (2021, April 23). Statement on universal affordable vaccination against coronavirus disease (COVID-19), international cooperation and intellectual property. United Nations Digital Library. https://digitallibrary.un.org/record/3921880?ln=en
- United Nations Economic, Social and Cultural Rights. (2000, August 11). General comment No.14: The right to the highest attainable standard of health (article 12). United Nations Digital Library. https://digitallibrary.un.org/record/425041?ln=en
- United Nations General Assembly. (1998, July 17). Rome Statute of the International Criminal Court (last amended 2010). https://www.refworld.org/docid/3ae6b3a84.html
- United Nations Millennium Development Goal Gap Task Force. (2015, September 18). MDG Gap Task Force Report 2015. United Nations Department of Economic and Social Affairs. https://www.un.org/development/desa/dpad/publication/taking-stock-of-the-global-partnership-for-development/
- United Nations News. (2021, February 17). COVID-19 vaccination ‘wildly uneven and unfair’: UN Secretary General. https://news.un.org/en/story/2021/02/1084962
- United Nations Secretary General. (2016). High-Level panel on access to medicines report: Promoting innovation and access to health technologies. http://www.unsgaccessmeds.org/final-report/
- United States Trade Representative. (2022, December 16). [Letter to U.S. International trade commission]. The United States representative executive office of the president Washington. Washington, D.C., United States of America.
- Velásquez, G., Madrid, Y., & Quick, J. D. (1998). Health reform and drug financing. World Health Organization. https://apps.who.int/iris/handle/10665/63839
- Wasserman, H. (2021, July 11). Breakthrough: J&J will allow SA to produce vaccine under licence, Ramaphosa says. news24. https://www.news24.com/fin24/companies/health/breakthrough-jj-will-allow-sa-to-produce-vaccine-under-licence-ramaphosa-says-20210711
- WHO Working Group on Amendments to the International Health Regulations. (2023, February 6). Report of the Review Committee regarding amendments to the International Health Regulations (2005). Second meeting of the working group on amendments to the international health regulations (2005). https://apps.who.int/gb/wgihr/pdf_files/wgihr2/A_WGIHR2_5-en.pdf
- Wingrove, J. (2021, June 30). World Bank announces deal to fund production of 500 million Covid-19 vaccine doses in South Africa. Blomberg News. https://www.news24.com/fin24/companies/world-bank-announces-deal-to-fund-500-million-vaccine-doses-for-sa-20210630
- Wirtz, V. J., Hogerziel, H. V., Gray, A. L., Bigdeli, M., de Joncheere, C. P., Ewen, M. A., Gyansa-Lutterodt, M., Jing, S., Luiza, V. L., Mbindyo, R. M., Moller, H., Mocheraud, C., Pecoul, B., Rago, L., Rashidian, A., Ross-Degnan, D., Stephens, P. N., Teerawattananon, Y., t Hoen, E. F. M., … Reich, M. R. (2016). Essential medicines for universal health coverage. The Lancet, 389(10067), 403–476. https://doi.org/10.1016/S0140-6736(16)31599-9
- World Health Organization. (2004, March). Equitable access to essential medicines: A framework for collective action. WHO Policy Perspectives on Medicines. https://apps.who.int/iris/handle/10665/68571
- World Health Organization. (2020, September 9). Fair allocation mechanism for COVID-19 vaccines through the COVAX Facility. https://www.who.int/publications/m/item/fair-allocation-mechanism-for-covid-19-vaccines-through-the-covax-facility
- World Health Organization. (2021a, November 29). Joint statement on dose donations of COVID-19 vaccines to African countries. https://www.who.int/news/item/29-11-2021-joint-statement-on-dose-donations-of-covid-19-vaccines-to-african-countries
- World Health Organization. (2021b, December 1). The world together: Establishment of an intergovernmental negotiating body to strengthen pandemic prevention, preparedness and response. World Health Assembly Second Special Session. https://apps.who.int/gb/ebwha/pdf_files/WHASSA2/SSA2(5)-en.pdf
- World Health Organization. (2022a, May 17). Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19. https://www.who.int/news/item/17-05-2022-interim-statement-on-the-use-of-additional-booster-doses-of-emergency-use-listed-mrna-vaccines-against-covid-19
- World Health Organization. (2022b, May 12). WHO and MPP announce agreement with NIH for COVID-19 health technologies. https://www.who.int/news/item/12-05-2022-who-and-mpp-annonce-agreement-with-nih-for-covid-19-health-technologies
- World Health Organization. (2023a). Covid dashboard. Retrieved August 21, 2023, from https://covid19.who.int
- World Health Organization. (2023b, February 1). Zero draft of the WHO CA+ for the consideration of the Intergovernmental Negotiating Body at its fourth meeting. Fourth meeting of the intergovernmental negotiating body. https://apps.who.int/gb/inb/pdf_files/inb4/A_INB4_3-en.pdf
- World Health Organization. (2023c, May 8). Global vaccine market report 2022: a shared understanding for equitable access to vaccines. https://www.who.int/publications/i/item/9789240062726
- World Health Organization, GAVI, & UNICEF. (2021, February 8). Costs of delivering COVID-19 vaccine in 92 AMC countries Updated estimates from COVAX Working Group on delivery costs. https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/costs-of-covid-19-vaccine-delivery-in-92amc_08.02.21.pdf
- World Trade Organization. (1995). Annex 1C: Agreement on trade-related aspects of intellectual property rights. https://www.wto.org/english/docs_e/legal_e/27-trips_01_e.htm
- World Trade Organization. (2001, November 14). Declaration on the TRIPS Agreement and Public Health. https://www.wto.org/english/thetwo e/minste/min01e/mindecltripse.htm
- World Trade Organization. (2022, June 17). Ministerial decision on the TRIPS agreement. https://docs.wto.org/doI2fe/Pages/SS/directdoc.aspx?filename=q:/WT/MIN22/30.pdf&Open=True
- Wouters, O. J., Shadlen, K. C., Salcher-Konrad, M., Pollard, A. J., Larson, H. J., Teerawattananon, Y., & Jit, M. (2021). Challenges in ensuring global access to COVID-19 vaccines: Production, affordability, allocation, and deployment. The Lancet, 397(10278), 1023–1034. https://doi.org/10.1016/S0140-6736(21)00306-8
- Yamin, A., & Farmer, P. (2022, June 7). Against Nihilism: Transformative human rights praxis for the future of global health. Open Global Rights. https://www.openglobalrights.org/against-nihilism-transformative-human-rights-praxis-for-the-future-of-global-health/
- Zaitchik, A. (2021, April 12). How Bill Gates impeded global access to COVID vaccines. New Republic. https://newrepublic.com/article/162000/bill-gates-impeded-global-access-covid-vaccines